While the mechanism by which PCSK9 regulates LDLR degradation is not fully

Nov 6, 2008 . It is believed that PCSK9 binds to LDL-receptor (LDLR) protein and prevents its

Jan 15, 2008 . Project Title, PCSK9-/- LDLR-/- mouse. Track Code, VAL-526-IRCM. Short

Apr 25, 2011 . New York. Running title: Evidence of LDLR degradation by PCSK9 in brain. . In

human PCSK9 substantially reduced hepatic LDLR pro- tein levels and resulted

Overexpression of PCSK9 in HepG2 cells caused a decrease in whole-cell and

The PCSK9 and ConA staining overlapped (Fig. 6B), which indicated that

Proprotein convertase subtilisin/kexin type 9 (PCSK9), in addition to LDLR . 10-

expression is modulated by PCSK9 in an LDLR-independent manner. . single

Familial Hypercholesterolemia Testing, LDLR, APOB Genetic Testing, Familial

The binding site of PCSK9 has been localized to the epidermal growth factor-like

Feb 18, 2011 . This multidomain protein interacts with the LDL receptor (LDLR), promoting

Jun 21, 2010 . The E3 ubiquitin ligase c-IAP1 regulates PCSK9-mediated LDLR degradation:

(11) localized the binding site of PCSK9 in the LDLR to the first epidermal growth

Jul 4, 2008 . When using or discussing LOVD please refer to: Fokkema IFAC, Den Dunnen JT

Apr 23, 2010 . PCSK9 binds to the low density lipoprotein receptor (LDLR) and leads to LDLR

Apr 17, 2009 . Antagonism of secreted PCSK9 increases low density lipoprotein receptor

CircuLex PCSK9-LDLR from MBL International. . Catalog Number, CY-8150.

Lipid Metabolism Related Kit. CY-8150 PCSK9-LDLR in vitro Binding Assay Kit(

Feb 12, 2008 . The structure of PCSK9 in complex with the LDLR EGF-A domain defines

FIGURE 8.5 Proposed interactions of PCSK9 with the LDLR. The. . Following

May 19, 2011 . A method of inhibiting PCSK9-induced LDLR degradation, or PCSK9-induced

Jul 13, 2007 . Notably, we found that in vitro wild-type PCSK9 binds LDLR with an ∼150-fold

PCSK9-LDLR. Background: PCSK9 (also known as neural apoptosis-regulated

May 4, 2011 . rapid clearance of PCSK9 from plasma, even in Ldlr. 2/2 . surface, and the

PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the

Come and meet us at the NCRI Cancer Conference 6-8th November in Liverpool Read

LNA ASO efficiently reduced the mRNA and protein levels of PCSK9 with a

Non-Radioisotopic Kit for Measuring PCSK9-LDLR interaction in vitro . The

The PCSK9-LDLR in vitro Binding Assay kit is a semi-quantitative solid phase

PCSK9 binds to the LDL receptor in vitro though LDLR EGF-A domain. Human

Binding affinities of wild-type human PCSK9 to LDLR were measured at pH 7.4 (

Objective—Proprotein convertase subtilisin/kexin 9 (PCSK9) promotes the

PCSK9 or mutants of PCSK9 and the LDLR would provide insight into the . cells

Oct 21, 2011 . antibody, J10 potently inhibit PCSK9 binding to LDLR extracellular domain (ECD

Coimmunoprecipitation and ligand blotting studies indicated that PCSK9 and

Secreted PCSK9 downregulates low density lipoprotein receptor through

PCSK9 silencing in LDLR heterozygous mice results in the expected phenotypic

Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density

The Proprotein Convertase PCSK9 Induces the Degradation of Low Density

that PCSK9 binds specifically to an EGF-like repeat (EGF-A) in LDLR and

It is believed that PCSK9 binds to LDL-receptor (LDLR) protein and prevents its

Apr 29, 2009 . To block secreted PCSK9 activity, LDLR (H306Y) sub-fragments were added to

LDL receptor was confirmed by using CircuLex PCSK9-LDLR in vitro Binding

Thus PCSK9 has emerged as an important player modulating LDLR levels and

Nov 11, 2011 . Domain organizations of LDLR and PCSK9. (A) The low-density lipoprotein

V. Table of Contents. Dedication i. Acknowledgements ii. Abstract iii. Table of

PCSK9 can also bind the LDLR intracellularly.3 Thus, by virtue of its role as a

Nov 1, 2006 . We conclude that secreted PCSK9 associates with the LDLR and reduces .

Mediating Cholesterol Homeostasis through SREBP-2 / LDLR / PCSK9

Sitemap